MediFind found 252 doctor with experience in Non-Small Cell Lung Cancer (NSCLC) near Amagasaki, 28. Of these, 180 are Experienced, 50 are Advanced, 15 are Distinguished and 7 are Elite.
Nobuyuki Katakami practices in Takarazuka, Japan. Mr. Katakami is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Squamous Cell Lung Carcinoma, and Tissue Biopsy.
Tomoya Kawaguchi practices in Osaka, Japan. Mr. Kawaguchi is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Endoscopy, and Tissue Biopsy.
Hiroshige Yoshioka practices in Osaka, Japan. Yoshioka is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Mastectomy.
Are you looking for a specific type of Non-Small Cell Lung Cancer (NSCLC)?
Common conditions include: EGFR Positive Lung Cancer, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
Motohiro Tamiya practices in Osaka, Japan. Tamiya is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleural Effusion, EGFR Positive Lung Cancer, and Endoscopy.
Kazuto Nishio practices in Osaka, Japan. Mr. Nishio is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer, and Tissue Biopsy.
Kazumi Nishino practices in Osaka, Japan. Mr. Nishino is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Junichi Soh practices in Osaka, Japan. Mr. Soh is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Osteotomy, and Endoscopy.
Yukinori Matsuo practices in Osaka, Japan. Matsuo is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Interstitial Lung Disease, and Acute Interstitial Pneumonia.
Kenichi Suda practices in Osaka, Japan. Mr. Suda is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC).
Satoshi Hara practices in Itami, Japan. Mr. Hara is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Takashi Yokoi practices in Nishinomiya-hama, Japan. Mr. Yokoi is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Soichiro Funaki practices in Nishinomiya-hama, Japan. Funaki is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Mediastinal Tumor, Thymectomy, and Lung Transplant.
Takeshi Morimoto practices in Nishinomiya-hama, Japan. Mr. Morimoto is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Venous Thromboembolism (VTE), Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Thrombectomy.
Yoshiki Negi practices in Nishinomiya-hama, Japan. Mr. Negi is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma.
Haruko Daga practices in Osaka, Japan. Ms. Daga is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Fumio Imamura practices in Osaka, Japan. Mr. Imamura is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.
Takayuki Shiroyama practices in Osaka, Japan. Mr. Shiroyama is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Pleural Effusion, and Endoscopy.
Hiroyasu Kaneda practices in Osaka, Japan. Kaneda is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Febrile Neutropenia.
Toru Kumagai practices in Osaka, Japan. Mr. Kumagai is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Pleural Effusion, and Tissue Biopsy.
Yasushi Shintani practices in Osaka, Japan. Shintani is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Mediastinal Tumor, Thymectomy, and Lung Transplant.
Last Updated: 02/22/2026


